These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25343023)

  • 1. A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role.
    Hage MP; Al-Badri MR; Azar ST
    Ther Adv Endocrinol Metab; 2014 Aug; 5(4):77-85. PubMed ID: 25343023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifaceted effects of hydroxychloroquine in human disease.
    Olsen NJ; Schleich MA; Karp DR
    Semin Arthritis Rheum; 2013 Oct; 43(2):264-72. PubMed ID: 23481418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
    Penn SK; Kao AH; Schott LL; Elliott JR; Toledo FG; Kuller L; Manzi S; Wasko MC
    J Rheumatol; 2010 Jun; 37(6):1136-42. PubMed ID: 20436082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine in rheumatic autoimmune disorders and beyond.
    Nirk EL; Reggiori F; Mauthe M
    EMBO Mol Med; 2020 Aug; 12(8):e12476. PubMed ID: 32715647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine in systemic and autoimmune diseases: Where are we now?
    Dima A; Jurcut C; Arnaud L
    Joint Bone Spine; 2021 May; 88(3):105143. PubMed ID: 33515791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
    Hu C; Lu L; Wan JP; Wen C
    Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How toxic is an old friend? A review of the safety of hydroxychloroquine in clinical practice.
    Fairley JL; Nikpour M; Mack HG; Brosnan M; Saracino AM; Pellegrini M; Wicks IP
    Intern Med J; 2023 Mar; 53(3):311-317. PubMed ID: 35969110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert Group Consensus Opinion: Role of Anti-inflammatory Agents in the Management of Type-2 Diabetes (T2D).
    Das AK; Kalra S; Tiwaskar M; Bajaj S; Seshadri K; Chowdhury S; Sahay R; Indurkar S; Unnikrishnan AG; Phadke U; Pareek A; Purkait I
    J Assoc Physicians India; 2019 Dec; 67(12):65-74. PubMed ID: 31801334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases.
    Dos Reis Neto ET; Kakehasi AM; de Medeiros Pinheiro M; Ferreira GA; Marques CDL; da Mota LMH; Dos Santos Paiva E; Pileggi GCS; Sato EI; Reis APMG; Xavier RM; Provenza JR
    Adv Rheumatol; 2020 Jun; 60(1):32. PubMed ID: 32517786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic effects of hydroxychloroquine in two Japanese patients with systemic lupus erythematosus.
    Hanai S; Kobayashi Y; Ichijo M; Ito R; Kobayashi K; Nakagomi D
    Diabetol Int; 2022 Apr; 13(2):447-451. PubMed ID: 35463861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial.
    Wasko MC; McClure CK; Kelsey SF; Huber K; Orchard T; Toledo FG
    Diabetologia; 2015 Oct; 58(10):2336-43. PubMed ID: 26197707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effectiveness of antimalarial drugs in rheumatic diseases.
    Aviña-Zubieta JA; Galindo-Rodriguez G; Newman S; Suarez-Almazor ME; Russell AS
    Ann Rheum Dis; 1998 Oct; 57(10):582-7. PubMed ID: 9893568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
    Abarientos C; Sperber K; Shapiro DL; Aronow WS; Chao CP; Ash JY
    Expert Opin Drug Saf; 2011 Sep; 10(5):705-14. PubMed ID: 21417950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge.
    Dima A; Jurcut C; Chasset F; Felten R; Arnaud L
    Ther Adv Musculoskelet Dis; 2022; 14():1759720X211073001. PubMed ID: 35186126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases.
    Rekedal LR; Massarotti E; Garg R; Bhatia R; Gleeson T; Lu B; Solomon DH
    Arthritis Rheum; 2010 Dec; 62(12):3569-73. PubMed ID: 20722019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic.
    Infante M; Ricordi C; Fabbri A
    J Diabetes; 2020 Sep; 12(9):659-667. PubMed ID: 32401405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.
    Mittal L; Zhang L; Feng R; Werth VP
    J Am Acad Dermatol; 2018 Jan; 78(1):100-106.e1. PubMed ID: 28989103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine Therapy and Serum Immunoglobulin Levels in Women with IgG Subclass Deficiency and Systemic Lupus Erythematosus, Sjögren Syndrome, and Rheumatoid Arthritis: A Retrospective Study.
    Barton JC; Barton JC; Bertoli LF
    Arch Immunol Ther Exp (Warsz); 2022 Apr; 70(1):14. PubMed ID: 35403913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial.
    Hartman O; Kovanen PT; Lehtonen J; Eklund KK; Sinisalo J
    Eur Heart J Cardiovasc Pharmacother; 2017 Apr; 3(2):92-97. PubMed ID: 28025216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.